HCC cells can develop resistance to the four Tyrosine Kinase Inhibitors (TKIs) as well as four cytotoxic chemotherapeutic medicines when exposed to TPX2 [67]. This evidence concerns the gene TPX2 and hepatocellular carcinoma.